Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,960.50    -12.00 (-0.61%)
Bid:
1,960.00
Ask:
1,960.50
Spread: 0.50 (0.026%)
Market Cap: £78.57b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

GSK

11 Jul 2022 17:30

RNS Number : 0768S
FTSE Russell
11 July 2022
 

 

 

GSK (UK): Demerger of Haleon (UK)Changes in FTSE UK Index Series

11 July 2022

Further to the FTSE Russell notice released 15 June 2022 and subject to the completion of the demerger of Haleon (UK, non-constituent) from GSK (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE 100 Index

18 July 2022

FTSE 350 Index

18 July 2022

FTSE All-Share Index

18 July 2022

FTSE 350 Higher Yield Index

18 July 2022

Techmark All Share Index

18 July 2022

FTSE UK Dividend + Index

18 July 2022

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1440

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2022 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSQFLFFLDLBBBF
456789101112
Date   Source Headline
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20253:30 pmRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSGSK submits Arexvy for adults 18+ with EMA
12th Jun 202511:00 amPRNDirector/PDMR Shareholding
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20253:30 pmRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSGSK - second tranche of share buyback programme
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20253:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:00 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSLinerixibat file accepted for review by US FDA
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 202512:00 pmRNSGSK stops Phase 3 trial on cUTIs for efficacy
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 202512:16 pmRNSpositive CHMP opinion on Blenrep in EU
23rd May 20257:00 amRNSFDA approves Nucala COPD indication
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20253:30 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSBlenrep for 2L+ multiple myeloma approved in Japan
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSGSK to acquire efimosfermin
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20253:30 pmRNSDirector/PDMR Shareholding
13th May 202512:56 pmRNSUpdate on belrestotug development programme
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20253:31 pmRNSBlock listing Interim Review
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20255:15 pmRNSDirector/PDMR Shareholding
8th May 20253:30 pmRNSDirector/PDMR Shareholding
8th May 202511:15 amRNSLinerixibat GLISTEN pIII trial data at EASL
456789101112

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BRSN
Berendsen
LSE
0.00%
MXP
MXP.L
LSE
0.00%
DOM
Dominos
LSE
-0.37%
HVN
Harvey Nash Group
LSE
0.00%
BEG
Begbies
LSE
1.67%
Trending
NANO
Nanoco
LSE
18.97%
QHE
Quantum Helium
LSE
6.38%
GST
GSTechnologies
LSE
-4.82%
ALRT
Defence Holdings
LSE
-8.82%
SEE
Seeing Machines
LSE
7.53%